The blockbuster GLP-1 drugs that have reshaped the treatment of diabetes and obesity may help prevent multiple substance use disorders — and reduce the tragic outcomes they cause, a large new study ...
Accumulating scientific evidence and industry interest from Eli Lilly, Altimmune and startup Baseline Therapeutics is driving further research on the therapeutic potential of GLP-1 receptor agonists ...
Hosted on MSN
GLP‑1 drugs may fight addiction across every major substance, according to a study of 600,000 people
(The Conversation) – A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for his diabetes, he lost interest in cigarettes. He ...
Hosted on MSN
Millions of US children have parents with substance use disorder, and the consequences are staggering − new research
About 1 in 4 U.S. children – nearly 19 million – have at least one parent with substance use disorder. This includes parents who misuse alcohol, marijuana, prescription opioids or illegal drugs. Our ...
Young adults who heavily use substances may report significantly poorer memory decades later, a new University of Michigan study suggests. Researchers tracked how frequently participants reported ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results